A miRNA machinery component DDX20 controls NF-κB via microRNA-140 function

Biochem Biophys Res Commun. 2012 Apr 13;420(3):564-9. doi: 10.1016/j.bbrc.2012.03.034. Epub 2012 Mar 16.

Abstract

Hepatocellular carcinoma is the third leading cause of cancer mortality worldwide, but the molecular mechanisms in tumorigenesis remain largely unknown. Previously, a DEAD-box protein DDX20, a component of microRNA-containing ribonucleoprotein complexes, was identified as a liver tumor suppressor candidate in an oncogenomics-based in vivo RNAi screen. However, the molecular mechanisms were unknown. Here, we show that deficiency of DDX20 results in the enhancement of NF-κB activity, a crucial intracellular signaling pathway closely linked with hepatocarcinogenesis. While DDX20 normally suppresses NF-κB activity by regulating NF-κB-suppressing miRNA-140 function, this suppressive effect was lost in DDX20-deficient cells. The impairment of miRNA function due to DDX20 deficiency appears to be miRNA species-specific at the point of loading miRNAs into the RNA-induced silencing complex. These results indicate that DDX20 deficiency enhances NF-κB activity by impairing the NF-κB-suppressive action of microRNAs, and suggest that dysregulation of the microRNA machinery components may also be involved in pathogenesis in various human diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Hepatocellular / genetics
  • Carcinoma, Hepatocellular / metabolism*
  • Cell Line, Tumor
  • DEAD Box Protein 20 / genetics
  • DEAD Box Protein 20 / metabolism*
  • Gene Expression Regulation, Neoplastic
  • Gene Knockdown Techniques
  • Humans
  • Liver Neoplasms / genetics
  • Liver Neoplasms / metabolism*
  • MicroRNAs / genetics
  • MicroRNAs / metabolism*
  • NF-kappa B / agonists
  • NF-kappa B / metabolism*
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • MicroRNAs
  • Mirn140 microRNA, human
  • NF-kappa B
  • Tumor Necrosis Factor-alpha
  • DDX20 protein, human
  • DEAD Box Protein 20